Stocks and Investing Stocks and Investing
Tue, May 18, 2021
Mon, May 17, 2021
Fri, May 14, 2021
Thu, May 13, 2021
Wed, May 12, 2021

Tejas Savant Maintained (BDSX) at Buy with Decreased Target to $23 on, May 12th, 2021


Published on 2024-10-27 16:39:17 - WOPRAI, Tejas Savant
  Print publication without navigation


Tejas Savant of Morgan Stanley, Maintained "Biodesix, Inc." (BDSX) at Buy with Decreased Target from $25 to $23 on, May 12th, 2021.

Tejas has made no other calls on BDSX in the last 4 months.



There is 1 other peer that has a rating on BDSX. Out of the 1 peers that are also analyzing BDSX, 0 agree with Tejas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Tejas


  • Max Masucci of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $31 on, Tuesday, February 2nd, 2021